New Article! Targeting Stem Cells Improve Immunotherapy Efficacy in Head & Neck Cancer
Many patients with advanced head and neck squamous cell carcinoma (HNSCC) treated with PD1 blockade, in addition to chemotherapy, experience a relapse leading to a resistance to therapy. To improve the efficacy of immunotherapy and prevent tumor relapse, researchers studying the role of cancer stem cells and the protein BMI1 have identified a potential new combination therapy to treat advanced HNSCC, the most common type of head and neck cancer.
New Article! No Increased Skin Cancer Risk With Topical Immunosuppressant Ointments
Adults with the chronic skin condition atopic dermatitis can rest easy in the knowledge that two topical immunosuppressant medications commonly prescribed to treat the condition do not appear to increase the risk for the most common forms of skin cancer, despite package label warnings to the contrary, researchers from Massachusetts General Hospital (MGH) found.
Statin Use May Protect Against Squamous Cell Carcinoma
The use of statin blood thinners may be protective against adverse outcomes in patients with head and neck squamous cell carcinoma (HNSCC), especially individuals with human papillomavirus (HPV), according to findings from a large, prospective study presented June 22 at the American Association for Cancer Research (AACR) Virtual Meeting II (Abstract 3391).